Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Validation of a therapeutic range for nitisinone in patients treated for tyrosinemia type 1 based on reduction of succinylacetone excretion.

Jack RM, Scott CR.

JIMD Rep. 2019 Mar 14;46(1):75-78. doi: 10.1002/jmd2.12023. eCollection 2019 Mar.

2.

One-year pilot study on the effects of nitisinone on melanin in patients with OCA-1B.

Adams DR, Menezes S, Jauregui R, Valivullah ZM, Power B, Abraham M, Jeffrey BG, Garced A, Alur RP, Cunningham D, Wiggs E, Merideth MA, Chiang PW, Bernstein S, Ito S, Wakamatsu K, Jack RM, Introne WJ, Gahl WA, Brooks BP.

JCI Insight. 2019 Jan 24;4(2). pii: 124387. doi: 10.1172/jci.insight.124387. [Epub ahead of print]

3.

Introduction: Liquid Biopsies.

Nagrath S, Jack RM.

Cancer J. 2018 Mar/Apr;24(2):59-60. doi: 10.1097/PPO.0000000000000313. No abstract available.

PMID:
29601330
4.

Lethal neonatal case and review of primary short-chain enoyl-CoA hydratase (SCEH) deficiency associated with secondary lymphocyte pyruvate dehydrogenase complex (PDC) deficiency.

Bedoyan JK, Yang SP, Ferdinandusse S, Jack RM, Miron A, Grahame G, DeBrosse SD, Hoppel CL, Kerr DS, Wanders RJA.

Mol Genet Metab. 2017 Apr;120(4):342-349. doi: 10.1016/j.ymgme.2017.02.002. Epub 2017 Feb 2. Review.

5.

Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease.

Nakagawa N, Barron L, Gomez IG, Johnson BG, Roach AM, Kameoka S, Jack RM, Lupher ML Jr, Gharib SA, Duffield JS.

JCI Insight. 2016 Dec 8;1(20):e87446. doi: 10.1172/jci.insight.87446.

6.

Ultra-Specific Isolation of Circulating Tumor Cells Enables Rare-Cell RNA Profiling.

Jack RM, Grafton MM, Rodrigues D, Giraldez MD, Griffith C, Cieslak R, Zeinali M, Kumar Sinha C, Azizi E, Wicha M, Tewari M, Simeone DM, Nagrath S.

Adv Sci (Weinh). 2016 Apr 18;3(9):1600063. eCollection 2016 Sep.

7.

Opportunities and Challenges for Pancreatic Circulating Tumor Cells.

Nagrath S, Jack RM, Sahai V, Simeone DM.

Gastroenterology. 2016 Sep;151(3):412-26. doi: 10.1053/j.gastro.2016.05.052. Epub 2016 Jun 20. Review.

PMID:
27339829
8.

Quantifying MMA by SLE LC-MS/MS: Unexpected challenges in assay development.

Lo SY, Gordon C, Sadilkova K, Jack RM, Dickerson JA.

Clin Biochem. 2016 Sep;49(13-14):967-72. doi: 10.1016/j.clinbiochem.2016.05.010. Epub 2016 May 18.

PMID:
27208560
9.

Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome.

Coughlin CR 2nd, van Karnebeek CD, Al-Hertani W, Shuen AY, Jaggumantri S, Jack RM, Gaughan S, Burns C, Mirsky DM, Gallagher RC, Van Hove JL.

Mol Genet Metab. 2015 Sep-Oct;116(1-2):35-43. doi: 10.1016/j.ymgme.2015.05.011. Epub 2015 May 23. Review.

PMID:
26026794
10.

Tacrolimus and sirolimus in capillary dried blood spots allows for remote monitoring.

Dickerson JA, Sinkey M, Jacot K, Stack J, Sadilkova K, Law YM, Jack RM.

Pediatr Transplant. 2015 Feb;19(1):101-6. doi: 10.1111/petr.12392. Epub 2014 Nov 21.

PMID:
25414084
11.

The survival of patients with high grade glioma from different ethnic groups in South East England.

Ratneswaren T, Jack RM, Tataru D, Davies EA.

J Neurooncol. 2014 Dec;120(3):531-6. doi: 10.1007/s11060-014-1582-3. Epub 2014 Aug 26.

PMID:
25154322
12.

Improving the value of costly genetic reference laboratory testing with active utilization management.

Dickerson JA, Cole B, Conta JH, Wellner M, Wallace SE, Jack RM, Rutledge J, Astion ML.

Arch Pathol Lab Med. 2014 Jan;138(1):110-3. doi: 10.5858/arpa.2012-0726-OA.

PMID:
24377818
13.

Another laboratory test utilization program: our approach to reducing unnecessary 1,25-dihydroxyvitamin D orders with a simple intervention.

Dickerson JA, Jack RM, Astion ML, Cole B.

Am J Clin Pathol. 2013 Sep;140(3):446-7. doi: 10.1309/AJCPQS40FZTLTQDH. No abstract available.

PMID:
23955464
14.

Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.

Sadilkova K, Dugaw K, Benjamin D, Jack RM.

Clin Chim Acta. 2013 Sep 23;424:253-7. doi: 10.1016/j.cca.2013.06.024. Epub 2013 Jul 3.

PMID:
23830883
15.

Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS.

Sadilkova K, Busby B, Dickerson JA, Rutledge JC, Jack RM.

Clin Chim Acta. 2013 Jun 5;421:152-6. doi: 10.1016/j.cca.2013.02.009. Epub 2013 Mar 5.

PMID:
23473895
16.

Under-filled blood collection tubes containing K2EDTA as anticoagulant are acceptable for automated complete blood counts, white blood cell differential, and reticulocyte count.

Xu M, Robbe VA, Jack RM, Rutledge JC.

Int J Lab Hematol. 2010 Oct;32(5):491-7. doi: 10.1111/j.1751-553X.2009.01211.x. Epub 2009 Dec 23.

PMID:
20041968
17.

Exposure to environmental tobacco smoke during pregnancy in rats yields less effect on indices of brain cell number and size than does postnatal exposure.

Gospe SM Jr, Joyce JA, Siebert JR, Jack RM, Pinkerton KE.

Reprod Toxicol. 2009 Jan;27(1):22-7. doi: 10.1016/j.reprotox.2008.11.049. Epub 2008 Nov 19.

PMID:
19059474
18.

In vitro comparison of coronal microleakage between Resilon alone and gutta-percha with a glass-ionomer intraorifice barrier using a fluid filtration model.

Jack RM, Goodell GG.

J Endod. 2008 Jun;34(6):718-20. doi: 10.1016/j.joen.2008.03.007. Epub 2008 Apr 15.

PMID:
18498898
19.

Fisher ratio method applied to third-order separation data to identify significant chemical components of metabolite extracts.

Pierce KM, Hoggard JC, Hope JL, Rainey PM, Hoofnagle AN, Jack RM, Wright BW, Synovec RE.

Anal Chem. 2006 Jul 15;78(14):5068-75.

PMID:
16841931
20.
21.

Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestations.

Feinberg BB, Jack RM, Mok SC, Anderson DJ.

Am J Reprod Immunol. 2005 Dec;54(6):352-7.

PMID:
16305660
22.

ETHE1 mutations are specific to ethylmalonic encephalopathy.

Tiranti V, Briem E, Lamantea E, Mineri R, Papaleo E, De Gioia L, Forlani F, Rinaldo P, Dickson P, Abu-Libdeh B, Cindro-Heberle L, Owaidha M, Jack RM, Christensen E, Burlina A, Zeviani M.

J Med Genet. 2006 Apr;43(4):340-6. Epub 2005 Sep 23.

23.

Algorithm for locating analytes of interest based on mass spectral similarity in GC x GC-TOF-MS data: analysis of metabolites in human infant urine.

Sinha AE, Hope JL, Prazen BJ, Nilsson EJ, Jack RM, Synovec RE.

J Chromatogr A. 2004 Nov 26;1058(1-2):209-15.

PMID:
15595670
24.

Systems-based design of bi-ligand inhibitors of oxidoreductases: filling the chemical proteomic toolbox.

Sem DS, Bertolaet B, Baker B, Chang E, Costache AD, Coutts S, Dong Q, Hansen M, Hong V, Huang X, Jack RM, Kho R, Lang H, Ma CT, Meininger D, Pellecchia M, Pierre F, Villar H, Yu L.

Chem Biol. 2004 Feb;11(2):185-94.

25.

Genome-wide profile of oxidoreductases in viruses, prokaryotes, and eukaryotes.

Kho R, Newman JV, Jack RM, Villar HO, Hansen MR.

J Proteome Res. 2003 Nov-Dec;2(6):626-32.

PMID:
14692456
26.

Expression of human paraoxonase (PON1) during development.

Cole TB, Jampsa RL, Walter BJ, Arndt TL, Richter RJ, Shih DM, Tward A, Lusis AJ, Jack RM, Costa LG, Furlong CE.

Pharmacogenetics. 2003 Jun;13(6):357-64.

PMID:
12777966
27.

A path from primary protein sequence to ligand recognition.

Kho R, Baker BL, Newman JV, Jack RM, Sem DS, Villar HO, Hansen MR.

Proteins. 2003 Mar 1;50(4):589-99.

PMID:
12577265
28.

Beta2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of beta2-glycoprotein I.

McNeeley PA, Dlott JS, Furie RA, Jack RM, Ortel TL, Triplett DA, Victoria EJ, Linnik MD.

Thromb Haemost. 2001 Aug;86(2):590-5.

PMID:
11522008
29.

Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism.

Graf WD, Unis AS, Yates CM, Sulzbacher S, Dinulos MB, Jack RM, Dugaw KA, Paddock MN, Parson WW.

Neurology. 2001 Aug 14;57(3):410-6.

PMID:
11502905
30.
31.

Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency.

Rettmer RL, Carlson TH, Origenes ML, Jack RM, Labb RF.

Pediatrics. 1999 Sep;104(3):e37.

PMID:
10469820
32.

Ahomocysteinemia in molybdenum cofactor deficiency.

Graf WD, Oleinik OE, Jack RM, Weiss AH, Johnson JL.

Neurology. 1998 Sep;51(3):860-2.

PMID:
9748040
33.

Complement receptor type 1 (CR1, CD35) is a receptor for C1q.

Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A.

Immunity. 1997 Sep;7(3):345-55.

34.

Lipid transfer from human epithelial cells to Pneumocystis carinii in vitro.

Furlong ST, Koziel H, Bartlett MS, McLaughlin GL, Shaw MM, Jack RM.

J Infect Dis. 1997 Mar;175(3):661-8.

PMID:
9041339
35.

Fetal origin of amniotic fluid polymorphonuclear leukocytes.

Sampson JE, Theve RP, Blatman RN, Shipp TD, Bianchi DW, Ward BE, Jack RM.

Am J Obstet Gynecol. 1997 Jan;176(1 Pt 1):77-81.

PMID:
9024093
36.

D-2-hydroxyglutaric aciduria: hypotonia, cortical blindness, seizures, cardiomyopathy, and cylindrical spirals in skeletal muscle.

Baker NS, Sarnat HB, Jack RM, Patterson K, Shaw DW, Herndon SP.

J Child Neurol. 1997 Jan;12(1):31-6. Erratum in: J Child Neurol 1997 Apr;12(3):227.

PMID:
9010793
37.

Plasma homocysteine and methionine concentrations in children with neural tube defects.

Graf WD, Oleinik OE, Jack RM, Eder DN, Shurtleff DB.

Eur J Pediatr Surg. 1996 Dec;6 Suppl 1:7-9.

PMID:
9008810
38.

Purification of human lung leukotriene C4 synthase and preparation of a polyclonal antibody.

Penrose JF, Spector J, Lam BK, Friend DS, Xu K, Jack RM, Austen KF.

Am J Respir Crit Care Med. 1995 Jul;152(1):283-9.

PMID:
7599836
39.

Hemolytically inactive C5b67 complex: an agonist of polymorphonuclear leukocytes.

Wang C, Barbashov S, Jack RM, Barrett T, Weller PF, Nicholson-Weller A.

Blood. 1995 May 1;85(9):2570-8.

PMID:
7727785
40.
41.

Regulation of C1q receptor expression on human polymorphonuclear leukocytes.

Jack RM, Lowenstein BA, Nicholson-Weller A.

J Immunol. 1994 Jul 1;153(1):262-9.

PMID:
7911495
42.

The role of complement component C3b and its receptors in sperm-oocyte interaction.

Anderson DJ, Abbott AF, Jack RM.

Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10051-5.

43.
44.

Purification of human leukotriene C4 synthase.

Penrose JF, Gagnon L, Goppelt-Struebe M, Myers P, Lam BK, Jack RM, Austen KF, Soberman RJ.

Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11603-6.

45.

Regulation of MHC class I synthesis and expression by human neutrophils.

Neuman E, Huleatt JW, Vargas H, Rupp EE, Jack RM.

J Immunol. 1992 Jun 1;148(11):3520-7.

PMID:
1534098
47.
48.

Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21).

Fearon DT, Klickstein LB, Wong WW, Wilson JG, Moore FD Jr, Weis JJ, Weis JH, Jack RM, Carter RH, Ahearn JA.

Prog Clin Biol Res. 1989;297:211-20. No abstract available.

PMID:
2531419
49.

Reference interval for prealbumin for children two to 36 months old.

Sherry B, Jack RM, Weber A, Smith AL.

Clin Chem. 1988 Sep;34(9):1878-80.

PMID:
3416437
50.

Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD.

Tsokos GC, Thyphronitis G, Jack RM, Finkelman FD.

J Immunol. 1988 Aug 15;141(4):1261-6.

PMID:
2969399

Supplemental Content

Support Center